Results 201 to 210 of about 21,046 (260)

Hepatocarcinoma

, 2004
openaire   +1 more source

Natural Compounds Derived from Chilean Species and Their Cytotoxic Potential Against Cancer. [PDF]

Cancers (Basel)
Koning T, Calaf GM.
europepmc   +1 more source

Corrigendum: CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cells. [PDF]

Front Oncol
Digiacomo G, Fumarola C, La Monica S, Bonelli M, Cavazzoni A, Galetti M, Terenziani R, Eltayeb K, Volta F, Zoppi S, Bertolini P, Missale G, Alfieri R, Petronini PG.   +13 more
europepmc   +1 more source

Exploration of signature-related FAM genes and correlation between FAM50A expression and the pathogenesis and prognosis of hepatocellular carcinoma. [PDF]

Transl Cancer Res
Wu S, Chen S, Sun X, Chen X.
europepmc   +1 more source

[Tamoxifen and hepatocarcinoma].

Revista de gastroenterologia de Mexico, 1999
openaire   +1 more source

Abnormally activated wingless/integrated signaling modulates tumor-associated macrophage polarization and potentially promotes hepatocarcinoma cell growth. [PDF]

World J Gastroenterol
Wang WL, Tam PKH, Chen Y.
europepmc   +1 more source

Palliative Homecare in Chronic Liver Disease: A Cohort Analysis of Factors and Outcomes Associated with Home Palliative Care in Patients with End-Stage Liver Disease. [PDF]

J Palliat Care
Oliveira HM, Rocha C, Rego MF, Nunes R.
europepmc   +1 more source

Atractylon inhibits hepatocellular carcinoma by inducing ferroptosis with increasing SLC39A14 expression. [PDF]

Sci Rep
Tang X, Luo M, Xu Y, Yi Y, Li J.
europepmc   +1 more source

The impact of intraoperative diagnosis of spontaneous bacterial peritonitis or bacterascites in liver transplantation. [PDF]

Clinics (Sao Paulo)
Menezes NQS, Freire MP, Oshiro ICV, Dominguez EHG, Moreira JM, Pereira JM, Andraus W, D'Albuquerque LAC, Abdala E, Song ATW.   +9 more
europepmc   +1 more source